| Interactions between Xenobiotics and DME (XEOTIC)
|
| Fungicide(s), Herbicide(s) or Insecticide(s) |
| Fungicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Polyhexamethyleneguanidine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00954
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Fungicide |
| DME Modulation |
Polyhexamethyleneguanidine inhibits the expression of DME NQO1 |
[1] |
| Herbicide |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Diquat |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00971
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Herbicide |
| DME Modulation |
Diquat induces the drug-metabolizing activity of DME NQO1 |
[2] |
| Monomethylarsonic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00982
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Herbicide |
| DME Modulation |
Monomethylarsonic acid induces the drug-metabolizing activity of DME NQO1 |
[3] |
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 17 Xenobiotics
|
| 1,6-hexamethylene diisocyanate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01093
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
1,6-hexamethylene diisocyanate up-regulates the expression of DME NQO1 |
[4] |
| 2-methyl-4-isothiazolin-3-one |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00890
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
2-methyl-4-isothiazolin-3-one up-regulates the expression of DME NQO1 |
[5] |
| Acrolein |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01186
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Acrolein induces the drug-metabolizing activity of DME NQO1 |
[6] |
| Acrylamide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01187
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Acrylamide inhibits the expression of DME NQO1 |
[7] |
| Acrylonitrile |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00992
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Acrylonitrile induces the drug-metabolizing activity of DME NQO1 |
[8] |
| Cacodylic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01231
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Cacodylic acid up-regulates the expression of DME NQO1 and leads to increasing the drug-metabolizing activity of this enzyme |
[9] |
| Cadmium |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01503
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Cadmium induces the drug-metabolizing activity of DME NQO1 |
[2] |
| Catechol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01240
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Catechol up-regulates the expression of DME NQO1 |
[10] |
| Chloropicrin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01247
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Chloropicrin up-regulates the expression of DME NQO1 |
[4], [11] |
| Cyanoginosin LR |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00965
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Cyanoginosin LR induces the drug-metabolizing activity of DME NQO1 |
[12] |
| Cynaropicrin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01269
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Cynaropicrin up-regulates the expression of DME NQO1 |
[13] |
| Mercuric chloride |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01508
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Mercuric chloride up-regulates the expression of DME NQO1 |
[14] |
| Ochratoxin A |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01407
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Ochratoxin A inhibits the drug-metabolizing activity of DME NQO1 |
[15] |
| Paraquat |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01422
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Paraquat inhibits the expression of DME NQO1 |
[16] |
| Plumbagin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01435
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Plumbagin up-regulates the expression of DME NQO1 |
[17] |
| Sarin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00779
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Sarin inhibits the expression of DME NQO1 |
[18] |
| Usnic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01497
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Usnic acid up-regulates the expression of DME NQO1 |
[19] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 4 Xenobiotics
|
| Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Carcinogen |
| DME Modulation |
Benzo(a)pyrene induces the drug-metabolizing activity of DME NQO1 |
[20], [21] |
| Ethyl methanesulfonate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00772
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Ethyl methanesulfonate up-regulates the expression of DME NQO1 |
[22] |
| Methylcholanthrene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00899
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Carcinogen |
| DME Modulation |
Methylcholanthrene induces the drug-metabolizing activity of DME NQO1 |
[23] |
| Polychlorinated biphenyls |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00776
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Polychlorinated biphenyls up-regulates the expression of DME NQO1 |
[17] |
| Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 7 Xenobiotics
|
| 2-tert-butylhydroquinone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01129
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Environmental Pollutant |
| DME Modulation |
2-tert-butylhydroquinone induces the drug-metabolizing activity of DME NQO1 |
[24] |
| Antimony potassium tartrate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01201
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Environmental Pollutant |
| DME Modulation |
Antimony potassium tartrate induces the drug-metabolizing activity of DME NQO1 |
[25] |
| Demethoxycurcumin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01271
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Environmental Pollutant |
| DME Modulation |
Demethoxycurcumin induces the drug-metabolizing activity of DME NQO1 |
[26] |
| Diazinon |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01274
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Environmental Pollutant |
| DME Modulation |
Diazinon up-regulates the expression of DME NQO1 |
[27] |
| Hexyl cinnamic aldehyde |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00985
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Environmental Pollutant |
| DME Modulation |
Hexyl cinnamic aldehyde up-regulates the expression of DME NQO1 |
[28] |
| Pterostilbene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01441
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Environmental Pollutant |
| DME Modulation |
Pterostilbene up-regulates the expression of DME NQO1 |
[29] |
| Sodium arsenate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01023
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Environmental Pollutant |
| DME Modulation |
Sodium arsenate up-regulates the expression of DME NQO1 |
[30] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 11 Xenobiotics
|
| N-hexane |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01016
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Health and Environmental Toxicant |
| DME Modulation |
N-hexane induces the drug-metabolizing activity of DME NQO1 |
[31] |
| Thiram |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00884
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health and Environmental Toxicant |
| DME Modulation |
Thiram up-regulates the expression of DME NQO1 |
[32] |
| 1-methyl-4-phenylpyridinium |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01103
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Health Hazard |
| DME Modulation |
1-methyl-4-phenylpyridinium induces the drug-metabolizing activity of DME NQO1 |
[33] |
| 3-morpholinopropyl isothiocyanate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01142
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
3-morpholinopropyl isothiocyanate up-regulates the expression of DME NQO1 |
[20] |
| 7-aminocephalosporanic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01173
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
7-aminocephalosporanic acid up-regulates the expression of DME NQO1 |
[4] |
| Diethylhexyl phthalate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01004
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Diethylhexyl phthalate up-regulates the expression of DME NQO1 |
[34] |
| Glycidamide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01009
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Glycidamide up-regulates the expression of DME NQO1 |
[35] |
| Lead |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01505
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Lead up-regulates the expression of DME NQO1 |
[36] |
| Molybdenum trioxide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01014
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Molybdenum trioxide up-regulates the expression of DME NQO1 |
[37], [38] |
| Pyruvaldehyde |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01448
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Pyruvaldehyde up-regulates the expression of DME NQO1 |
[39] |
| Toluene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01489
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Toluene up-regulates the expression of DME NQO1 |
[40] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
| Coal tar |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00755
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Coal tar up-regulates the expression of DME NQO1 |
[41], [42] |
| Dust |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01284
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Dust up-regulates the expression of DME NQO1 |
[43] |
| Particulate matter |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00919
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Particulate matter up-regulates the expression of DME NQO1 |
[44] |
| Polyphenols |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01578
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Polyphenols up-regulates the expression of DME NQO1 |
[17] |
| Tobacco smoke pollution |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00821
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Mixture |
| DME Modulation |
Tobacco smoke pollution up-regulates the expression of DME NQO1 |
[45] |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 14 Xenobiotics
|
| Cinnamic aldehyde |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01253
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Cinnamic aldehyde induces the drug-metabolizing activity of DME NQO1 |
[46] |
| Cyanidin 3-O-glucoside |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01535
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Cyanidin 3-O-glucoside up-regulates the expression of DME NQO1 |
[47], [48] |
| Daphnetin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01536
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Daphnetin induces the drug-metabolizing activity of DME NQO1 |
[49] |
| Genipin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01545
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Genipin induces the drug-metabolizing activity of DME NQO1 |
[50] |
| Glucobrassicin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01548
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Glucobrassicin inhibits the drug-metabolizing activity of DME NQO1 |
[51] |
| Guggulsterone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01579
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Guggulsterone up-regulates the expression of DME NQO1 |
[52] |
| Hesperetin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00856
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Hesperetin induces the drug-metabolizing activity of DME NQO1 |
[53] |
| Isoflavone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01553
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Isoflavone up-regulates the expression of DME NQO1 |
[54], [55] |
| Ligustilide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01558
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Ligustilide up-regulates the expression of DME NQO1 |
[56] |
| Linalool |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01366
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Linalool up-regulates the expression of DME NQO1 |
[57] |
| Quinone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01450
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Quinone up-regulates the expression of DME NQO1 |
[16] |
| Sanguinarine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00865
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Sanguinarine inhibits the expression of DME NQO1 |
[18] |
| Sesquiterpene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00814
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Sesquiterpene up-regulates the expression of DME NQO1 |
[58] |
| Taxifolin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01591
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Taxifolin induces the drug-metabolizing activity of DME NQO1 |
[59] |
| Plant Extract |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Angelicae sinensis extract |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00825
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Plant Extract |
| DME Modulation |
Angelicae sinensis extract up-regulates the expression of DME NQO1 |
[60] |
| Plant extracts |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01574
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Plant Extract |
| DME Modulation |
Plant extracts induces the drug-metabolizing activity of DME NQO1 |
[61] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 49 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen inhibits the drug-metabolizing activity of DME NQO1 |
[62] |
| Adefovir dipivoxil |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00745
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Adefovir dipivoxil inhibits the expression of DME NQO1 |
[63] |
| Amoxicillin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00246
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Amoxicillin up-regulates the expression of DME NQO1 |
[64] |
| Ampicillin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00096
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Ampicillin up-regulates the expression of DME NQO1 |
[65] |
| Arsenic trioxide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Arsenic trioxide inhibits the drug-metabolizing activity of DME NQO1 |
[66] |
| Aspirin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00213
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Aspirin induces the drug-metabolizing activity of DME NQO1 |
[67] |
| Avobenzone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00411
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Avobenzone up-regulates the expression of DME NQO1 |
[68] |
| Belinostat |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00193
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Belinostat up-regulates the expression of DME NQO1 |
[44] |
| Bortezomib |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00159
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Bortezomib up-regulates the expression of DME NQO1 |
[69] |
| Bosentan |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00148
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Bosentan up-regulates the expression of DME NQO1 |
[70] |
| Capsaicin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00178
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Capsaicin inhibits the drug-metabolizing activity of DME NQO1 |
[71] |
| Cidofovir |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00132
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cidofovir inhibits the expression of DME NQO1 |
[63] |
| Cisplatin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cisplatin induces the drug-metabolizing activity of DME NQO1 |
[72] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME NQO1 |
[73], [74] |
| Daunorubicin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00351
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Daunorubicin inhibits the drug-metabolizing activity of DME NQO1 |
[75] |
| Decitabine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00168
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Decitabine up-regulates the expression of DME NQO1 |
[76] |
| Deferoxamine mesylate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00286
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Deferoxamine mesylate inhibits the expression of DME NQO1 |
[77] |
| Dexamethasone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00088
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Dexamethasone up-regulates the expression of DME NQO1 |
[78] |
| Diclofenac |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00352
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Diclofenac induces the drug-metabolizing activity of DME NQO1 |
[79] |
| Dicumarol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00203
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Dicumarol inhibits the drug-metabolizing activity of DME NQO1 (IC50 = 0.0026 microM) |
[80] |
| Dimethyl fumarate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00172
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Dimethyl fumarate induces the drug-metabolizing activity of DME NQO1 |
[81], [82] |
| Disulfiram |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00028
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Disulfiram up-regulates the expression of DME NQO1 |
[28] |
| Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Doxorubicin hydrochloride up-regulates the expression of DME NQO1 |
[83] |
| Estradiol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Estradiol inhibits the drug-metabolizing activity of DME NQO1 |
[84] |
| Etoposide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00121
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Etoposide up-regulates the expression of DME NQO1 |
[85] |
| Ferric citrate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00135
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Ferric citrate induces the drug-metabolizing activity of DME NQO1 |
[86] |
| Flurbiprofen sodium |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00296
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Flurbiprofen sodium induces the drug-metabolizing activity of DME NQO1 |
[79] |
| Hydrogen peroxide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00388
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Hydrogen peroxide inhibits the drug-metabolizing activity of DME NQO1 |
[87] |
| Hydroquinone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00430
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Hydroquinone up-regulates the expression of DME NQO1 and leads to increasing the drug-metabolizing activity of this enzyme |
[88] |
| Ifosfamide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00046
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Ifosfamide inhibits the expression of DME NQO1 |
[63] |
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00301
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Irinotecan hydrochloride inhibits the expression of DME NQO1 |
[89] |
| Isoniazid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00224
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Isoniazid up-regulates the expression of DME NQO1 |
[64] |
| Ivermectin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00244
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Ivermectin inhibits the drug-metabolizing activity of DME NQO1 |
[75] |
| Ketoconazole |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00251
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Ketoconazole induces the drug-metabolizing activity of DME NQO1 |
[90] |
| Lapatinib ditosylate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00304
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Lapatinib ditosylate up-regulates the expression of DME NQO1 |
[91] |
| Metformin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00365
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Metformin inhibits the drug-metabolizing activity of DME NQO1 |
[92] |
| Mifepristone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00127
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Mifepristone inhibits the drug-metabolizing activity of DME NQO1 |
[93] |
| Penicillin G |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00437
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Penicillin G up-regulates the expression of DME NQO1 |
[94] |
| Penicillin V |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00099
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Penicillin V up-regulates the expression of DME NQO1 |
[95] |
| Rosiglitazone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00380
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Rosiglitazone induces the drug-metabolizing activity of DME NQO1 |
[96], [97] |
| Simvastatin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00125
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Simvastatin up-regulates the expression of DME NQO1 |
[98] |
| Sulindac |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00177
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Sulindac induces the drug-metabolizing activity of DME NQO1 |
[99] |
| Tretinoin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Tretinoin up-regulates the expression of DME NQO1 |
[100] |
| Urethane |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00435
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Urethane inhibits the expression of DME NQO1 |
[101] |
| Benzoic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00447
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Benzoic acid up-regulates the expression of DME NQO1 |
[28] |
| Clodronic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00465
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Clodronic acid inhibits the expression of DME NQO1 |
[63] |
| Daidzein |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00439
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Daidzein inhibits the expression of DME NQO1 |
[102] |
| Hemin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01328
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Hemin induces the drug-metabolizing activity of DME NQO1 |
[103] |
| Linoleic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01367
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Linoleic acid up-regulates the expression of DME NQO1 |
[104] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
| Curcumin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00683
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Curcumin induces the drug-metabolizing activity of DME NQO1 |
[105] |
| LY-353381 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00847
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
LY-353381 up-regulates the expression of DME NQO1 |
[106] |
| Resveratrol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00568
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Resveratrol inhibits the expression of DME NQO1 |
[107] |
| Sulforafan |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01478
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Sulforafan induces the drug-metabolizing activity of DME NQO1 |
[108] |
| Vitamin E |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00547
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Vitamin E up-regulates the expression of DME NQO1 |
[109] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 11 Xenobiotics
|
| Butyric acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01230
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2/3 |
| DME Modulation |
Butyric acid induces the drug-metabolizing activity of DME NQO1 |
[21] |
| Phenol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00558
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2/3 |
| DME Modulation |
Phenol up-regulates the expression of DME NQO1 |
[110], [111] |
| Andrographolide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00543
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Andrographolide induces the drug-metabolizing activity of DME NQO1 |
[112] |
| Bisphenol A |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Bisphenol A up-regulates the expression of DME NQO1 |
[113] |
| Chlorogenic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01246
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Chlorogenic acid up-regulates the expression of DME NQO1 |
[62] |
| Ethanol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00539
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Ethanol inhibits the expression of DME NQO1 |
[114] |
| Genistein |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00557
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Genistein inhibits the expression of DME NQO1 |
[102] |
| MS-275 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
MS-275 up-regulates the expression of DME NQO1 |
[44] |
| Phenethyl isothiocyanate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00596
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Phenethyl isothiocyanate up-regulates the expression of DME NQO1 |
[115] |
| Sulindac sulfide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00656
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Sulindac sulfide up-regulates the expression of DME NQO1 |
[116] |
| ZIO-101 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00673
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
ZIO-101 induces the drug-metabolizing activity of DME NQO1 |
[117] |
| Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 7 Xenobiotics
|
| Dinitrochlorobenzene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00571
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Dinitrochlorobenzene up-regulates the expression of DME NQO1 |
[28] |
| Ellagic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01287
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Ellagic acid induces the drug-metabolizing activity of DME NQO1 |
[118] |
| Naringenin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00573
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Naringenin induces the drug-metabolizing activity of DME NQO1 |
[119] |
| Quercetin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00538
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Quercetin induces the drug-metabolizing activity of DME NQO1 |
[120] |
| Sodium arsenite |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Sodium arsenite induces the drug-metabolizing activity of DME NQO1 |
[121] |
| Thioctic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01483
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Thioctic acid induces the drug-metabolizing activity of DME NQO1 |
[122], [123] |
| Xanthohumol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00636
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Xanthohumol induces the drug-metabolizing activity of DME NQO1 |
[124] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 6 Xenobiotics
|
| (+)-JQ1 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
(+)-JQ1 induces the drug-metabolizing activity of DME NQO1 |
[125] |
| Esculetin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01291
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
Esculetin up-regulates the expression of DME NQO1 and leads to increasing the drug-metabolizing activity of this enzyme |
[126] |
| Isoliquiritigenin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00710
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
Isoliquiritigenin induces the drug-metabolizing activity of DME NQO1 |
[127] |
| Bay 11-7085 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01214
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
Bay 11-7085 up-regulates the expression of DME NQO1 |
[128] |
| CP-673,451 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01262
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
CP-673,451 inhibits the expression of DME NQO1 |
[129] |
| Eugenol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00885
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
Eugenol induces the drug-metabolizing activity of DME NQO1 |
[130] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 11 Xenobiotics
|
| 4'-bromoflavone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01150
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
4'-bromoflavone induces the drug-metabolizing activity of DME NQO1 |
[131] |
| 4-hydroxy-2-nonenal |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00869
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
4-hydroxy-2-nonenal induces the drug-metabolizing activity of DME NQO1 |
[132] |
| 9,10-phenanthrenequinone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00871
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
9,10-phenanthrenequinone induces the drug-metabolizing activity of DME NQO1 |
[132] |
| Aluminum maltolate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01193
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
Aluminum maltolate inhibits the drug-metabolizing activity of DME NQO1 |
[133] |
| Beta-naphthoflavone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01220
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
Beta-naphthoflavone induces the drug-metabolizing activity of DME NQO1 |
[134] |
| ES-936 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01162
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
ES-936 inhibits the drug-metabolizing activity of DME NQO1 |
[135], [136] |
| GW9662 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01123
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
GW9662 up-regulates the expression of DME NQO1 |
[128] |
| Isopropanol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01128
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
Isopropanol up-regulates the expression of DME NQO1 |
[28] |
| Phenylmercuric acetate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00818
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
Phenylmercuric acetate up-regulates the expression of DME NQO1 and leads to increasing the drug-metabolizing activity of this enzyme |
[137] |
| Sirtinol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01471
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
Sirtinol up-regulates the expression of DME NQO1 |
[138] |
| TIMBD |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01148
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
TIMBD induces the drug-metabolizing activity of DME NQO1 |
[139] |
| Other Chemical Compound(s) or Element(s) |
| Chemical Compound |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Gold |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01504
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Chemical Compound |
| DME Modulation |
Gold up-regulates the expression of DME NQO1 |
[140] |
|
|
|
|
|
|